Bone Biologics Corp. (BBLG)
0.3948
-0.01
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
0.3917
0.00 (0.00%)
After-Hours: 20:00
Bone Biologics EPS Diluted (Quarterly) : -0.4306 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4306 |
| March 31, 2026 | -0.4267 |
| December 31, 2025 | -0.3814 |
| September 30, 2025 | -0.3714 |
| June 30, 2025 | -1.328 |
| March 31, 2025 | -1.917 |
| December 31, 2024 | -3.091 |
| September 30, 2024 | -0.5367 |
| June 30, 2024 | -0.6708 |
| March 31, 2024 | -1.310 |
| December 31, 2023 | -2.901 |
| September 30, 2023 | -4.900 |
| June 30, 2023 | -13.52 |
| March 31, 2023 | -55.25 |
| December 31, 2022 | 14.01 |
| September 30, 2022 | -28.27 |
| June 30, 2022 | -10.88 |
| March 31, 2022 | -95.92 |
| December 31, 2021 | -4.121 |
| September 30, 2021 | -41.99 |
| June 30, 2021 | -40.55 |
| March 31, 2021 | -35.59 |
| December 31, 2020 | -8.874 |
| September 30, 2020 | -32.48 |
| June 30, 2020 | -31.33 |
| Date | Value |
|---|---|
| March 31, 2020 | -49.21 |
| December 31, 2019 | -10.39 |
| September 30, 2019 | -46.19 |
| June 30, 2019 | -76.07 |
| March 31, 2019 | -115.62 |
| December 31, 2018 | -33.36 |
| September 30, 2018 | -19.62 |
| June 30, 2018 | -171.42 |
| March 31, 2018 | -180.00 |
| December 31, 2017 | -360.00 |
| September 30, 2017 | -2199.24 |
| June 30, 2017 | 900.00 |
| March 31, 2017 | -2880.00 |
| December 31, 2016 | -9019.80 |
| September 30, 2016 | -660.00 |
| June 30, 2016 | -780.00 |
| March 31, 2016 | -1200.00 |
| December 31, 2015 | -1486.62 |
| September 30, 2015 | -660.00 |
| June 30, 2015 | -180.00 |
| March 31, 2015 | -420.00 |
| December 31, 2014 | -262.14 |
| September 30, 2014 | -1200.00 |
| June 30, 2014 | -240.00 |
| January 31, 2014 | -2.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.7737M |
| Total Expenses (Quarterly) | 0.7737M |
| Enterprise Value | -3.317M |
| Earnings Yield | -407.8% |
| Normalized Earnings Yield | -408.00 |